Cargando…

Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus

New therapies are needed for patients with T-cell lymphoblastic leukemia (T-ALL) who do not respond to standard chemotherapy. Our previous studies showed that the mTORC1 inhibitor everolimus increases reactive oxygen species (ROS) levels, decreases the levels of NADPH and glucose-6-phosphate dehydro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silic-Benussi, Micol, Sharova, Evgeniya, Corradin, Alberto, Urso, Loredana, Raimondi, Vittoria, Cavallari, Ilaria, Buldini, Barbara, Francescato, Samuela, Minuzzo, Sonia A., D’Agostino, Donna M., Ciminale, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045900/ https://www.ncbi.nlm.nih.gov/pubmed/36978873 http://dx.doi.org/10.3390/antiox12030625

Ejemplares similares

mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells
por: Silic-Benussi, Micol, et al.
Publicado: (2022)

The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers
por: Cavallari, Ilaria, et al.
Publicado: (2021)

Nanoparticles as Tools to Target Redox Homeostasis in Cancer Cells
por: Ciccarese, Francesco, et al.
Publicado: (2020)

Selective killing of human T-ALL cells: an integrated approach targeting redox homeostasis and the OMA1/OPA1 axis
por: Silic-Benussi, Micol, et al.
Publicado: (2018)

MiR-150 in HTLV-1 infection and T-cell transformation
por: D’Agostino, Donna M., et al.
Publicado: (2022)

Mitochondrial Proteins Coded by Human Tumor Viruses
por: Cavallari, Ilaria, et al.
Publicado: (2018)

Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives
por: Cavallari, Ilaria, et al.
Publicado: (2019)

Expression of miR-34a in T-Cells Infected by Human T-Lymphotropic Virus 1
por: Sharma, Varun K., et al.
Publicado: (2018)

Metabolic rewiring and redox alterations in malignant pleural mesothelioma
por: Urso, Loredana, et al.
Publicado: (2019)

Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists
por: Urso, Loredana, et al.
Publicado: (2017)

Control of ROS production and T-cell turnover by HTLV-p13
por: Silic-Benussi, Micol, et al.
Publicado: (2011)

Kinetics and intracellular compartmentalization of HTLV-1 gene expression
por: Rende, Francesca, et al.
Publicado: (2011)

Involvement of NADPH Oxidase 1 in Liver Kinase B1-Mediated Effects on Tumor Angiogenesis and Growth
por: Zulato, Elisabetta, et al.
Publicado: (2018)

Repurposing verapamil for prevention of cognitive decline in sporadic Alzheimer's disease
por: Ahmed, Heba A., et al.
Publicado: (2021)

Functional properties and sequence variation of HTLV-1 p13
por: Omsland, Maria, et al.
Publicado: (2020)

Prognostic Stratification of Bladder Cancer Patients with a MicroRNA-Based Approach
por: Cavallari, Ilaria, et al.
Publicado: (2020)

Verapamil, a possible repurposed therapeutic candidate for stroke under hyperglycemia
por: Ismael, Saifudeen, et al.
Publicado: (2022)

Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters
por: Sharova, Evgeniya, et al.
Publicado: (2021)

Oncogenic pathways and the electron transport chain: a dangeROS liaison
por: Raimondi, Vittoria, et al.
Publicado: (2019)

Verapamil in Diabetes
por: Poudel, Resham Raj, et al.
Publicado: (2017)

A circulating miRNA assay as a first-line test for prostate cancer screening
por: Sharova, Evgeniya, et al.
Publicado: (2016)

Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation
por: Pastò, Anna, et al.
Publicado: (2014)

Preclinical evidence to support repurposing everolimus for craving reduction during protracted drug withdrawal
por: Chiu, Alvin S., et al.
Publicado: (2021)

Converging Strategies in Expression of Human Complex Retroviruses
por: Cavallari, Ilaria, et al.
Publicado: (2011)

Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1-Mutant Diffuse Intrinsic Pontine Glioma
por: Carvalho, Diana M., et al.
Publicado: (2022)

Post-transcriptional Regulation of HTLV Gene Expression: Rex to the Rescue
por: D’Agostino, Donna M., et al.
Publicado: (2019)

Rewiring of Lipid Metabolism and Storage in Ovarian Cancer Cells after Anti-VEGF Therapy
por: Curtarello, Matteo, et al.
Publicado: (2019)

Influence of verapamil on the pharmacokinetics of oridonin in rats
por: Liu, Jing, et al.
Publicado: (2019)

Pharmacokinetic Interaction between Metformin and Verapamil in Rats: Inhibition of the OCT2-Mediated Renal Excretion of Metformin by Verapamil
por: Han, Seung Yon, et al.
Publicado: (2020)

Trandolapril/verapamil combination in hypertensive diabetic patients
por: García Donaire, José A, et al.
Publicado: (2007)

Verapamil: what is the mechanism of its anticarcinogenic activity?
por: Brambilla, G.
Publicado: (1994)

Verapamil Inhibits Aspergillus Biofilm, but Antagonizes Voriconazole
por: Nazik, Hasan, et al.
Publicado: (2017)

Verapamil Targets Membrane Energetics in Mycobacterium tuberculosis
por: Chen, Chao, et al.
Publicado: (2018)

Verapamil as an Adjuvant Treatment for Drug-Resistant Epilepsy
por: Lakshmikanthcharan, S., et al.
Publicado: (2018)

Effects of Verapamil and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban
por: Kim, Minsoo, et al.
Publicado: (2019)

Verapamil and vasospastic angina: underuse in the elderly population
por: Humbert, Xavier, et al.
Publicado: (2017)

Verapamil and Alzheimer’s Disease: Past, Present, and Future
por: Popović, Natalija, et al.
Publicado: (2020)

Fine tuning of the temporal expression of HTLV-1 and HTLV-2
por: Cavallari, Ilaria, et al.
Publicado: (2013)

Vorolanib and everolimus: Lenvatinib and everolimus part deux, or something new?
por: Chehrazi-Raffle, Alexander, et al.
Publicado: (2020)

Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia
por: Veltri, Giulia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pea42fcssc54s92ingee40onms